CLX vs KMB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CLX · Clorox$99.96 ▲ 0.26%
KMB · Kimberly-Clark$108.43 ▼ 1.84%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CLX -1.1%
- KMB +10.5%
Head to head
| Metric | CLX | KMB |
|---|---|---|
| Price | $99.96 | $108.43 |
| Change today | ▲ 0.26% | ▼ 1.84% |
| Market cap | $12.11B | $66.54B |
| Return, 3 months | -6.1% | +1.6% |
| Return, year to date | +2.7% | +11.5% |
| Return, 1 year | -3.6% | +9.7% |
| P/E (TTM) | 18.0 | 10.9 |
| P/B | -310.4 | 22.7 |
| P/E percentile vs own 5y | 17th | 0th |
| Dividend yield | 4.97% | 4.70% |
| Revenue growth (YoY, latest qtr) | -2.0% | +0.6% |
| Net profit growth (YoY) | -50.3% | -31.6% |
| Gross margin | 42.3% | 36.8% |
| Operating margin | 13.2% | 15.2% |
| Net margin | 8.7% | 11.8% |
| Return on equity | 285.6% | 129.4% |
| Analyst target vs. price | -10.9% | +11.7% |
| Analyst buy share | 0% | 50% |
| RSI (14) | 74 | 56 |
| 30-day volatility | 33.7% | 32.8% |
| Max drawdown, 1 year | -35.2% | -21.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- KMB is the largest of the group by market value.
- KMB has returned the most over the past year.
- KMB carries the lowest trailing P/E.
- CLX pays the highest dividend yield.
- KMB is growing revenue fastest.
- KMB keeps the most profit per dollar of sales.
- KMB has been the calmest stock over the last 30 days.